Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population.
暂无分享,去创建一个
Nancy G Doerrer | Herman Autrup | Elaine A Cohen Hubal | Daland R Juberg | Linda S Birnbaum | Christopher J Portier | Ronald N Hines | William Slikker | Dana Sargent | Klaus Olejniczak | W. Slikker | R. Brent | R. Luebke | L. Birnbaum | C. Portier | E. C. Cohen Hubal | H. Autrup | N. Doerrer | R. Hines | K. Olejniczak | D. Juberg | Robert L Brent | Christian Laurent | Robert Luebke | D. Sargent | C. Laurent
[1] W. Slikker,et al. Incorporating children's toxicokinetics into a risk framework. , 2004, Environmental health perspectives.
[2] Philip J. Landrigan,et al. Biological markers in environmental health research , 1987 .
[3] T. Kamataki,et al. Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens , 1991, Japanese journal of cancer research : Gann.
[4] Richard Reiss,et al. A framework and case study for exposure assessment in the Voluntary Children's Chemical Evaluation Program. , 2003, Risk analysis : an official publication of the Society for Risk Analysis.
[5] E. Delvin,et al. Congenital hypothyroidism: from paracelsus to molecular diagnosis. , 2006, Clinical biochemistry.
[6] A. Faden,et al. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. , 2006, CNS drug reviews.
[7] T. Hammond,et al. Differential effects of two NMDA receptor antagonists on cognitive-behavioral development in nonhuman primates I. , 2001, Neurotoxicology and teratology.
[8] A. Done. Developmental pharmacology , 1964, Clinical pharmacology and therapeutics.
[9] A. Bleyer,et al. Cancer in 15- to 29-year-olds by primary site. , 2006, The oncologist.
[10] D. Hewitt,et al. A survey of childhood malignancies. , 1962, British medical journal.
[11] Ronald N Hines,et al. The ontogeny of drug metabolism enzymes and implications for adverse drug events. , 2008, Pharmacology & therapeutics.
[12] B. D. Beck,et al. The development of a stochastic physiologically-based pharmacokinetic model for lead. , 2001, The Science of the total environment.
[13] Jane Alcorn,et al. Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants Part I , 2002, Clinical pharmacokinetics.
[14] E. Hall,et al. Lessons we have learned from our children: cancer risks from diagnostic radiology , 2002, Pediatric Radiology.
[15] R. Brent,et al. Utilization of developmental basic science principles in the evaluation of reproductive risks from pre- and postconception environmental radiation exposures. , 1999, Teratology.
[16] J. Wehner,et al. Effects of sodium ascorbate, sodium saccharin and ammonium chloride on the male rat urinary bladder. , 1995, Carcinogenesis.
[17] John C Lipscomb,et al. Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. , 2007, Current drug metabolism.
[18] Harvey J Clewell,et al. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[19] D. Cory-Slechta. Studying toxicants as single chemicals: does this strategy adequately identify neurotoxic risk? , 2005, Neurotoxicology.
[20] O. Niwa,et al. Chromosome Aberrations do not Persist in the Lymphocytes or Bone Marrow Cells of Mice Irradiated In Utero or Soon after Birth , 2007, Radiation research.
[21] J. Issa,et al. Age-Related DNA Methylation Changes in Normal Human Prostate Tissues , 2007, Clinical Cancer Research.
[22] J. Stevens,et al. Epirubicin Glucuronidation and UGT2B7 Developmental Expression , 2006, Drug Metabolism and Disposition.
[23] D. Eaton. Biotransformation enzyme polymorphism and pesticide susceptibility. , 2000, Neurotoxicology.
[24] B. Ames,et al. Chemical carcinogenesis: too many rodent carcinogens. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Olsen,et al. GENETIC EFFECTS OF RADIOTHERAPY FOR CHILDHOOD CANCER , 2003, Health physics.
[26] B. Sonawane,et al. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.
[27] A. Glazko,et al. Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. , 1960, The New England journal of medicine.
[28] V G Zartarian,et al. Children's exposure assessment: a review of factors influencing Children's exposure, and the data available to characterize and assess that exposure. , 2000, Environmental health perspectives.
[29] D. Bell,et al. Genetic susceptibility: significance in risk assessment. , 1998, Toxicology letters.
[30] Human toxicity of PBDDs and PBDFs. , 1995, Environmental health perspectives.
[31] J. Pin,et al. Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.
[32] Louis W. Chang,et al. Handbook of Developmental Neurotoxicology , 1998 .
[33] Dana B. Barr,et al. Biologic Monitoring of Exposure to Environmental Chemicals throughout the Life Stages: Requirements and Issues for Consideration for the National Children’s Study , 2005, Environmental health perspectives.
[34] S. Bonassi,et al. Children's exposure to environmental pollutants and biomarkers of genetic damage. I. Overview and critical issues. , 2006, Mutation research.
[35] Fan Wang,et al. DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies , 2008, Cancer Epidemiology Biomarkers & Prevention.
[36] Walter Schmitt,et al. A Mechanistic Approach for the Scaling of Clearance in Children , 2006, Clinical pharmacokinetics.
[37] D. G. McCarver,et al. Applicability of the principles of developmental pharmacology to the study of environmental toxicants. , 2004, Pediatrics.
[38] P. Wedlund. The CYP2C19 Enzyme Polymorphism , 2000, Pharmacology.
[39] Lindsey A. Torre,et al. Cancer Facts and Figures for Hispanics/Latinos 2015-2017 , 1905 .
[40] O. Pelkonen,et al. Characterization of human fetal hepatic cytochrome P-450-associated 7-ethoxyresorufin O-deethylase and aryl hydrocarbon hydroxylase activities by monoclonal antibodies. , 1987, Developmental pharmacology and therapeutics.
[41] R W Miller,et al. Childhood and adult cancer after intrauterine exposure to ionizing radiation. , 1999, Teratology.
[42] P G Mulder,et al. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. , 2000, Environmental health perspectives.
[43] Melvin E Andersen,et al. Dose-dependent transitions in mechanisms of toxicity. , 2004, Toxicology and applied pharmacology.
[44] T. Guilarte. Pb2+ inhibits NMDA receptor function at high and low affinity sites: developmental and regional brain expression. , 1997, Neurotoxicology.
[45] Peter Wood,et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. , 2005, Blood.
[46] G. Kearns,et al. Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny , 2003, Clinical pharmacology and therapeutics.
[47] A. Tward,et al. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism , 2005, Pharmacogenetics and genomics.
[48] Henrik Toft Sørensen,et al. The Danish National Birth Cohort - its background, structure and aim , 2001, Scandinavian journal of public health.
[49] Ling-Zhi Wang,et al. A warfarin‐dosing model in Asians that uses single‐nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9 , 2006, Clinical pharmacology and therapeutics.
[50] E. Boersma,et al. Environmental exposure to polychlorinated biphenyls (PCBs) and dioxins. Consequences for longterm neurological and cognitive development of the child lactation. , 2000, Advances in experimental medicine and biology.
[51] C. Kimmel,et al. Children's health risk assessment: incorporating a lifestage approach into the risk assessment process. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.
[52] H. Nakanishi,et al. Involvement of enhanced sensitivity of N-methyl-d-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity , 2001, Brain Research.
[53] John Balbus,et al. CHILDREN's SUSCEPTIBILITY TO CHEMICALS: A REVIEW BY DEVELOPMENTAL STAGE , 2004, Journal of toxicology and environmental health. Part B, Critical reviews.
[54] A. Herbst,et al. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. , 1971, The New England journal of medicine.
[55] R. Scheuplein,et al. Differential Sensitivity of Children and Adults to Chemical Toxicity , 2004, Human and Ecological Risk Assessment: An International Journal.
[56] J. Xue,et al. Identifying Childhood Age Groups for Exposure Assessments and Monitoring , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[57] David R. Williams,et al. Vulnerability as a Function of Individual and Group Resources in Cumulative Risk Assessment , 2007, Environmental health perspectives.
[58] J. Lipscomb,et al. Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling , 2008, Drug Metabolism and Disposition.
[59] Dale Hattis,et al. Physiologically Based Pharmacokinetic (PBPK) Modeling of Caffeine and Theophylline in Neonates and Adults: Implications for Assessing Children's Risks from Environmental Agents , 2004, Journal of toxicology and environmental health. Part A.
[60] L. Anderson,et al. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. , 2000, Environmental health perspectives.
[61] W. Evans,et al. Liver volume as a determinant of drug clearance in children and adolescents. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[62] S. Bonassi,et al. Children's exposure to environmental pollutants and biomarkers of genetic damage. II. Results of a comprehensive literature search and meta-analysis. , 2006, Mutation research.
[63] M. Siimes,et al. Reproduction following treatment for childhood leukemia: a population-based prospective cohort study of fertility and offspring. , 1991, Medical and pediatric oncology.
[64] Amy D. Kyle,et al. Integrated Assessment of Environment and Health: America’s Children and the Environment , 2005, Environmental Health Perspectives.
[65] R. Luebke,et al. Suppression of Immune Function and Susceptibility to Infections in Humans: Association of Immune Function with Clinical Disease , 2004, Journal of immunotoxicology.
[66] U. Klotz,et al. P-glycoprotein function in the elderly , 2004, European Journal of Clinical Pharmacology.
[67] Y. Turpaz,et al. CYP4F2 genetic variant alters required warfarin dose. , 2008, Blood.
[68] T. Cresteil,et al. Evidence of impaired cisapride metabolism in neonates. , 2001, British journal of clinical pharmacology.
[69] T. Tammela,et al. Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994. , 2000, Environmental health perspectives.
[70] L. Goldman. Children--unique and vulnerable. Environmental risks facing children and recommendations for response. , 1995, Environmental health perspectives.
[71] R. Brent,et al. A pediatric perspective on the unique vulnerability and resilience of the embryo and the child to environmental toxicants: the importance of rigorous research concerning age and agent. , 2004, Pediatrics.
[72] E. Boersma. Environmental exposure to polychlorinated biphenyls (PCBs) and dioxins , 2001 .
[73] G W Kneale,et al. Radiation dose effects in relation to obstetric x-rays and childhood cancers. , 1970, Lancet.
[74] J. Byrne. Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring. , 1999, Teratology.
[75] S G Selevan,et al. Identifying critical windows of exposure for children's health. , 2000, Environmental health perspectives.
[76] DNA repair, genetic instability, and cancer , 2007 .
[77] A. J. Scheetz,et al. Modulation of NMDA receptor function: implications for vertebrate neural development , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[78] K. C. Kanelakis,et al. Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[79] L. Goldman,et al. Serum polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans among people eating contaminated home-produced eggs and beef. , 1999, Environmental health perspectives.
[80] G. Kimmel. An overview of children as a special population--relevance to predictive biomarkers. , 2005, Toxicology and applied pharmacology.
[81] T. Todani,et al. Liver volume in children measured by computed tomography , 1997, Pediatric Radiology.
[82] T. Hammond,et al. Differential effects of two NMDA receptor antagonists on cognitive--behavioral performance in young nonhuman primates II. , 2001, Neurotoxicology and teratology.
[83] B. Sonawane,et al. A framework for assessing risks to children from exposure to environmental agents. , 2004, Environmental health perspectives.
[84] H. Özkaynak,et al. Exposure Assessment Implications for the Design and Implementation of the National Children’s Study , 2005, Environmental health perspectives.
[85] R. Albertini,et al. The Use of Biomonitoring Data in Exposure and Human Health Risk Assessments , 2006, Environmental health perspectives.
[86] J. Burke,et al. The challenge of assessing children's residential exposure to pesticides , 2000, Journal of Exposure Analysis and Environmental Epidemiology.
[87] A. Fantel,et al. Human embryonic cytochrome P450S: phenoxazone ethers as probes for expression of functional isoforms during organogenesis. , 1991, Biochemical pharmacology.
[88] G. Kearns,et al. Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[89] S. Holgate,et al. Environmental risk factors and allergic bronchial asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[90] B. Lin,et al. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. , 1993, American journal of human genetics.
[91] C. Willhite,et al. Derivation of a Bisphenol a Oral Reference Dose (RfD) and Drinking-Water Equivalent Concentration , 2008, Journal of toxicology and environmental health. Part B, Critical reviews.
[92] Michael Dourson,et al. Differential sensitivity of children and adults to chemical toxicity. I. Biological basis. , 2002, Regulatory toxicology and pharmacology : RTP.
[93] Q. Fernaǹdo. Metal speciation in environmental and biological systems. , 1995, Environmental health perspectives.
[94] J. Hakkola,et al. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. , 1994, Biochemical pharmacology.
[95] R. Smialowicz,et al. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. , 2000, Environmental health perspectives.
[96] M. Morandi,et al. Exposure Assessment in the National Children’s Study: Introduction , 2005, Environmental health perspectives.
[97] M. Ticku,et al. Ethanol and Regulation of the NMDA Receptor Subunits in Fetal Cortical Neurons , 1998, Journal of neurochemistry.
[98] Richard D. Wood,et al. Nucleotide Excision Repair in Mammalian Cells* , 1997, The Journal of Biological Chemistry.
[99] J. Neel,et al. Changing perspectives on the genetic doubling dose of ionizing radiation for humans, mice, and Drosophila. , 1999, Teratology.
[100] R. Brent,et al. The Vulnerability, Sensitivity, and Resiliency of the Developing Embryo, Infant, Child, and Adolescent to the Effects of Environmental Chemicals, Drugs, and Physical Agents as Compared to the Adult , 2004, Pediatrics.
[101] T. Chang,et al. Cumulative environmental changes, skewed antigen exposure, and the increase of allergy. , 2008, Advances in immunology.
[102] R. Connelly,et al. Cancer in offspring of long‐term survivors of childhood and adolescent cancer , 1988 .
[103] Ronald N Hines,et al. Human hepatic CYP2E1 expression during development. , 2003, The Journal of pharmacology and experimental therapeutics.
[104] C Timchalk,et al. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[105] E. Mayatepek,et al. Transient trimethylaminuria in childhood , 1998, Acta paediatrica.
[106] Division on Earth. Pesticides in the Diets of Infants and Children , 1993 .
[107] K Krishnan,et al. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene. , 2006, Toxicology and applied pharmacology.
[108] David H. Chen,et al. The Comparative Immunotoxicity of Five Selected Compounds Following Developmental or Adult Exposure , 2006, Journal of toxicology and environmental health. Part B, Critical reviews.
[109] Ja Wilson,et al. Principles and practice of screening for disease , 1968 .
[110] E. Faustman,et al. Mechanisms underlying Children's susceptibility to environmental toxicants. , 2000, Environmental health perspectives.
[111] Jennifer Seed,et al. Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.
[112] M. Wei,et al. Effects of co-administration of antioxidants and arsenicals on the rat urinary bladder epithelium. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[113] E. Hubal,et al. Measuring Potential Dermal Transfer of a Pesticide to Children in a Child Care Center , 2005, Environmental health perspectives.
[114] R. Brent. LAURISTON S. TAYLOR LECTURE: FIFTY YEARS OF SCIENTIFIC RESEARCH: THE IMPORTANCE OF SCHOLARSHIP AND THE INFLUENCE OF POLITICS AND CONTROVERSY , 2007, Health physics.
[115] A. Vingerhoets,et al. Prenatal diethylstilbestrol exposure and self-reported immune-related diseases. , 1998, European journal of obstetrics, gynecology, and reproductive biology.
[116] J. Olsen,et al. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study. , 2004, American journal of human genetics.
[117] M. Piccinni,et al. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy , 2000, Journal of Neuroimmunology.
[118] Chronic Disease Division. Cancer facts and figures , 2010 .
[119] J. V. van Engelen,et al. Risk assessment of chemicals and pharmaceuticals in the pediatric population: a workshop report. , 2005, Regulatory toxicology and pharmacology : RTP.
[120] S. Lewis,et al. The comparative radiation genetics of humans and mice. , 1990, Annual review of genetics.
[121] A. Stewart. The carcinogenic effects of low level radiation. A re-appraisal of epidemiologists methods and observations. , 1973, Health physics.
[122] Amin Rostami-Hodjegan,et al. Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children , 2006, Clinical pharmacokinetics.
[123] Rodney R. Dietert,et al. Lead and Immune Function , 2006, Critical reviews in toxicology.
[124] J. Olney,et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. , 1999, Science.
[125] R. Brent. Biological Factors Related to Male Mediated Reproductive and Developmental Toxicity , 1994 .
[126] S. Cohen,et al. Tumorigenicity of sodium ascorbate in male rats. , 1998, Cancer research.
[127] G. B. Louis,et al. Principles for evaluating health risks in children associated with exposure to chemicals , 2006 .
[128] Jacqueline Moya,et al. A lifestage approach to assessing children's exposure. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.
[129] T. Stephenson. How children's responses to drugs differ from adults. , 2005, British journal of clinical pharmacology.
[130] D. Bellinger. Children's cognitive health: the influence of environmental chemical exposures. , 2007, Alternative therapies in health and medicine.
[131] R. Dingledine,et al. The glutamate receptor ion channels. , 1999, Pharmacological reviews.
[132] A. Rettie,et al. Developmental Expression of Human Hepatic CYP2C9 and CYP2C19 , 2004, Journal of Pharmacology and Experimental Therapeutics.
[133] C. Kimmel,et al. Developmental stage sensitivity and mode of action information for androgen agonists and antagonists. , 2001, The Science of the total environment.
[134] R. Nygaard,et al. Second Malignant Neoplasms in Patients Treated for Childhood Leukemia: A Population‐based Cohort Study from the Nordic Countries , 1991, Acta paediatrica Scandinavica.
[135] Jun-yan Hong,et al. Genetic polymorphism of cytochrome P450 as a biomarker of susceptibility to environmental toxicity. , 1997, Environmental health perspectives.
[136] C. Bearer,et al. How are children different from adults? , 1995, Environmental health perspectives.
[137] A. Tward,et al. Expression of human paraoxonase (PON1) during development. , 2003, Pharmacogenetics.
[138] M. Piepenbrink,et al. Perinatal Immunotoxicity: Why Adult Exposure Assessment Fails to Predict Risk , 2005, Environmental health perspectives.
[139] Harvey J Clewell,et al. Bayesian Estimation of Pharmacokinetic and Pharmacodynamic Parameters in a Mode‐of‐Action‐Based Cancer Risk Assessment for Chloroform , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[140] Dale L Preston,et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. , 2008, Journal of the National Cancer Institute.
[141] Harvey J Clewell,et al. Perchlorate and Radioiodide Kinetics Across Life Stages in the Human: Using PBPK Models to Predict Dosimetry and Thyroid Inhibition and Sensitive Subpopulations Based on Developmental Stage , 2007, Journal of toxicology and environmental health. Part A.